Analysen von Matthew Weston
| 16.03.26 | Bayer Buy | UBS AG | |
| 06.03.26 | Roche Buy | UBS AG | |
| 05.03.26 | Merck Buy | UBS AG | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 10.02.26 | AstraZeneca Buy | UBS AG | |
| 30.01.26 | Roche Buy | UBS AG | |
| 16.01.26 | Roche Buy | UBS AG | |
| 16.01.26 | AstraZeneca Buy | UBS AG | |
|
Werbung
|
|||
| 15.12.25 | Sanofi Buy | UBS AG | |
| 11.12.25 | Roche Buy | UBS AG | |
| 05.12.25 | Roche Buy | UBS AG | |
| 19.11.25 | Roche Buy | UBS AG | |
| 14.11.25 | Merck Buy | UBS AG | |
| 13.11.25 | Merck Buy | UBS AG | |
| 10.11.25 | Roche Buy | UBS AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
| 31.10.25 | AstraZeneca Buy | UBS AG | |
| 29.10.25 | Merck Buy | UBS AG | |
| 27.10.25 | Sanofi Buy | UBS AG | |
| 24.10.25 | Sanofi Buy | UBS AG | |
| 23.10.25 | Roche Buy | UBS AG | |
| 20.10.25 | Merck Buy | UBS AG | |
| 17.10.25 | Merck Buy | UBS AG | |
| 13.10.25 | AstraZeneca Buy | UBS AG | |
| 13.10.25 | Roche Buy | UBS AG | |
| 03.10.25 | Sanofi Buy | UBS AG | |
| 23.09.25 | Roche Buy | UBS AG | |
| 09.09.25 | Sanofi Buy | UBS AG | |
| 04.09.25 | Sanofi Buy | UBS AG | |
| 04.09.25 | Roche Buy | UBS AG | |
| 27.08.25 | Sanofi Buy | UBS AG | |
| 07.08.25 | Merck Buy | UBS AG | |
| 29.07.25 | AstraZeneca Buy | UBS AG | |
| 14.07.25 | AstraZeneca Buy | UBS AG | |
| 16.06.25 | Roche Buy | UBS AG | |
| 29.04.25 | AstraZeneca Buy | UBS AG | |
| 25.04.25 | Merck Buy | UBS AG | |
| 25.04.25 | Roche Buy | UBS AG | |
| 24.04.25 | Roche Buy | UBS AG | |
| 14.04.25 | Roche Buy | UBS AG | |
| 10.04.25 | AstraZeneca Buy | UBS AG | |
| 07.04.25 | Roche Buy | UBS AG | |
| 01.04.25 | AstraZeneca Buy | UBS AG | |
| 17.03.25 | AstraZeneca Buy | UBS AG | |
| 12.03.25 | Roche Buy | UBS AG | |
| 12.03.25 | AstraZeneca Buy | UBS AG | |
| 12.03.25 | Merck Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |
| 10.03.25 | AstraZeneca Buy | UBS AG | |